| Original language | English (US) |
|---|---|
| Pages (from-to) | 1462-1464 |
| Number of pages | 3 |
| Journal | Journal of Allergy and Clinical Immunology: In Practice |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2020 |
ASJC Scopus subject areas
- Immunology and Allergy
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
An observed serving dose may not be necessary following a standard divided-dose FPIES oral food challenge. / Guenther, Mariam W.; Crain, Maria; Parrish, Christopher P. et al.
In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, No. 4, 04.2020, p. 1462-1464.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - An observed serving dose may not be necessary following a standard divided-dose FPIES oral food challenge
AU - Guenther, Mariam W.
AU - Crain, Maria
AU - Parrish, Christopher P.
AU - Bird, J. Andrew
N1 - Funding Information: Conflicts of interest: M. Crain reports being on an allied health advisory board for DBV Technologies and Aimmune Therapeutics for their peanut products. C. P. Parrish reports personal fees from Aimmune Therapeutics; grants and nonfinancial support from DBV Technologies; and grants from the National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID) and Novartis, outside the submitted work. J. A. Bird reports personal fees from Food Allergy Research and Education, Nutricia North America, Prota Therapeutics, Allergy Therapeutics Ltd, AllerGenis, Abbott Nutrition International, and Pharm-Olam International Ltd; personal fees and nonfinancial support from the American College of Allergy, Asthma and Immunology; grants from Nestle Health Sciences, NIH-NIAID, Novartis, and Food Allergy Research and Education; personal fees and other fees from Pfizer Pharmaceuticals; grants, personal fees, and nonfinancial support from Aimmune Therapeutics; and grants and personal fees from DBV Technologies, outside the submitted work. M. W. Guenther reports no relevant conflicts of interest.
PY - 2020/4
Y1 - 2020/4
UR - http://www.scopus.com/inward/record.url?scp=85075817805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075817805&partnerID=8YFLogxK
U2 - 10.1016/j.jaip.2019.10.041
DO - 10.1016/j.jaip.2019.10.041
M3 - Article
C2 - 31726232
AN - SCOPUS:85075817805
VL - 8
SP - 1462
EP - 1464
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
SN - 2213-2198
IS - 4
ER -